Information Team news
Open Door - November 2009 page 12
- MS Trust books recognised at BMA awards
- Research on the web
- Have you taken part in a clinical trial, or chosen not to?
- Thank you to people with PPMS
MS Trust books recognised at BMA awards
Two books published by the MS Trust were highly commended at the BMA Patient Information Awards in September.
MS Explained was described as "a superb booklet and with excellent referencing."
Falls - managing the ups and downs of MS was praised for "practical and simple solutions to everyday challenges."
This is the third consecutive year that MS Trust publications have been winners at the BMA Awards, which aim to encourage the production of accessible, evidence based and well designed information.
- MS Explained - read, order or download
- Falls - managing the ups and downs of MS - read, order or download
Research on the web
The research section of our website will keep you up to date with all the latest news and views on MS research from around the world.
- Latest MS research - summaries of newly published research articles
- Drugs in development - latest data and announcements of clinical studies for new MS treatments, including cladribine, fingolimod and teriflunomide
- Getting involved in research - what taking part in a clinical study might entail and details of new studies which are looking for participants.
Have you taken part in a clinical trial, or chosen not to?
If so, we'd like to hear from you, whatever your experiences, good or bad. Your contribution may help other people to decide whether to commit to enrolling on a study, or not.
Thank you to people with PPMS
Thank you to everyone who completed our recent questionnaire on primary progressive MS. We were overwhelmed by the response and are now using your comments and experiences to shape the content of the book. The huge response means that we will not be able to contact everyone who has offered to review the publication, so we would like to take this opportunity to express our appreciation for your time and the invaluable information you have shared with us.
